THOMAS GAVIN: Open Payments
NPI 1932252756 · PLATTSBURGH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,085 in 110 payments from 19 companies in 2025. Trend: 2023 $1,895 · 2024 $2,141 · 2025 $2,085
Food & beverage: $2,085
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 22 | $454 |
| Novo Nordisk Inc | 20 | $413 |
| ABBVIE INC. | 18 | $302 |
| GlaxoSmithKline, LLC. | 10 | $187 |
| PFIZER INC. | 11 | $153 |
| Lilly USA, LLC | 7 | $149 |
| Otsuka America Pharmaceutical, Inc. | 4 | $78 |
| Axsome Therapeutics, Inc. | 3 | $56 |
| Amgen Inc. | 3 | $46 |
| Astellas Pharma US Inc | 2 | $41 |
Products named: AIRSUPRA, QULIPTA, Rybelsus, Ozempic, FARXIGA, TRELEGY ELLIPTA, MOUNJARO, NURTEC ODT.
Industry payments across NY — which companies pay providers there.
